Belluscura (BELL)

Sector:

Health Care

Index:

FTSE AIM All-Share

48.00p
   
  • Change Today:
      5.50p
  • 52 Week High: 122.50
  • 52 Week Low: 39.00
  • Currency: UK Pounds
  • Shares Issued: 123.02m
  • Volume: 194,059
  • Market Cap: £59.05m

Belluscura Overview

Belluscura focuses on novel oxygen-based treatment platforms that can be adapted and applied in a wide range of markets beyond those traditionally applicable to a single product or product line. Its range of portable products will be lighter / more adaptable / have higher O₂ capacity than existing oxygen enrichment products. Whilst potentially useful for recovering COVID patients, it has a wide range of use for sufferers of pneumonia / COPD (i.e. asthma/ emphysema /chronic bronchitis) and other respiratory illnesses.

1 Day Chart

1 Day Chart

6 Month Chart

6 Month Chart
Barclays logo

Digital Look Charts Sponsored by Barclays Stockbrokers

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn -1234.0% n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue 174.0 n/a
Pr/Book 3.0  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Belluscura Fundamentals

Year Ending Revenue ($m) Pre-tax ($m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-20 n/a (1.98) (0.04)¢ n/a n/a n/a n/a 0.0%
31-Dec-21 0.42 (5.21) (0.06)¢ n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Belluscura Company Announcements

Price Monitoring Extension 27-Jan-2023 14:00 RNS
Placing of Unsecured Convertible Loan Notes 27-Jan-2023 12:41 RNS
Second Price Monitoring Extn 24-Jan-2023 16:40 RNS

Belluscura ShareCast News

Belluscura makes 'considerable progress' in 2022 13-Jan-2023 ShareCast
Belluscura signs manufacturing deal in China 30-Mar-2022 ShareCast
Belluscura expectations for oxygen concentrator ... 04-Nov-2021 ShareCast

Latest Belluscura Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Belluscura Market Data

Currency UK Pounds
Share Price 48.00p
Change Today 5.50p
% Change 12.94 %
52 Week High 122.50
52 Week Low 39.00
Volume 194,059
Shares Issued 123.02m
Market Cap £59.05m

Belluscura Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
4.22% below the market average4.22% below the market average4.22% below the market average4.22% below the market average4.22% below the market average
8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average8.57% above the sector average
Price Trend
65.74% below the market average65.74% below the market average65.74% below the market average65.74% below the market average65.74% below the market average
53.85% below the sector average53.85% below the sector average53.85% below the sector average53.85% below the sector average53.85% below the sector average
Income Not Available
Growth Not Available

Belluscura Dividends

No dividends found

Trades for 27-Jan-2023

Time Volume / Share Price
17:07 20,000 @ 48.00p
16:03 2,000 @ 46.77p
16:00 3,000 @ 46.70p
15:21 5,000 @ 46.10p
15:18 15,000 @ 46.90p

Belluscura Key Personnel

CEO Robert “Bob” Rauker
CFO Anthony “Tony” Dyer

Top of Page